{"entity":{"type":"insider","cik":"0001518611","url":"/insider/0001518611","json_url":"/insider/0001518611.json","name":"Sibold William John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":8,"first":"2024-09-11","last":"2026-07-20","span_basis":"filed_date"},"name_variants":[{"name":"Sibold William John","source":"filing","n_filings":8,"first_seen":"2024-09-11","last_seen":"2026-07-20"}],"transactions":[{"id":6220087,"accession":"0001628280-26-048919","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001628280-26-048919","line_url":"/filing/0001628280-26-048919","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001518611","owner_name":"Sibold William John","owner_display_name":"Sibold William John","owner_url":"/insider/0001518611","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":547.30138116,"price_display":"547.30","price_state":"stated","total_value":1368253.4529,"total_display":"1,368,253.45","total_whole":"1,368,253","shares_owned_after":209810.0,"shares_owned_after_display":"209,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-20","filed_date":"2026-07-20","scope":"insider","n_lines":10},{"id":5766699,"accession":"0001628280-26-015769","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-015769","line_url":"/filing/0001628280-26-015769#line-2","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001518611","owner_name":"Sibold William John","owner_display_name":"Sibold William John","owner_url":"/insider/0001518611","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1663.0,"shares_display":"1,663","price_per_share":431.94,"price_display":"431.94","price_state":"stated","total_value":718316.22,"total_display":"718,316.22","total_whole":"718,316","shares_owned_after":161829.0,"shares_owned_after_display":"161,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-06","scope":"insider"},{"id":5814100,"accession":"0001628280-26-003468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-003468","line_url":"/filing/0001628280-26-003468#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001518611","owner_name":"Sibold William John","owner_display_name":"Sibold William John","owner_url":"/insider/0001518611","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1577.0,"shares_display":"1,577","price_per_share":492.42,"price_display":"492.42","price_state":"stated","total_value":776546.34,"total_display":"776,546.34","total_whole":"776,546","shares_owned_after":148497.0,"shares_owned_after_display":"148,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-26","scope":"insider"},{"id":4504726,"accession":"0001628280-25-055430","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-055430","line_url":"/filing/0001628280-25-055430#line-2","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001518611","owner_name":"Sibold William John","owner_display_name":"Sibold William John","owner_url":"/insider/0001518611","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":575.34,"price_display":"575.34","price_state":"stated","total_value":1380816.0,"total_display":"1,380,816.00","total_whole":"1,380,816","shares_owned_after":150074.0,"shares_owned_after_display":"150,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-04","scope":"insider"},{"id":4364023,"accession":"0001518611-25-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001518611-25-000009","line_url":"/filing/0001518611-25-000009#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001518611","owner_name":"Sibold William John","owner_display_name":"Sibold William John","owner_url":"/insider/0001518611","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7279.0,"shares_display":"7,279","price_per_share":445.63,"price_display":"445.63","price_state":"stated","total_value":3243740.77,"total_display":"3,243,740.77","total_whole":"3,243,741","shares_owned_after":102474.0,"shares_owned_after_display":"102,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-09","filed_date":"2025-09-09","scope":"insider"},{"id":4120741,"accession":"0001518611-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001518611-25-000007","line_url":"/filing/0001518611-25-000007","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001518611","owner_name":"Sibold William John","owner_display_name":"Sibold William John","owner_url":"/insider/0001518611","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7616.0,"shares_display":"7,616","price_per_share":400.17809464285716,"price_display":"400.18","price_state":"stated","total_value":3047756.3688,"total_display":"3,047,756.37","total_whole":"3,047,756","shares_owned_after":110884.0,"shares_owned_after_display":"110,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-21","scope":"insider","n_lines":2},{"id":4772173,"accession":"0001628280-25-002666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-002666","line_url":"/filing/0001628280-25-002666#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001518611","owner_name":"Sibold William John","owner_display_name":"Sibold William John","owner_url":"/insider/0001518611","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1584.0,"shares_display":"1,584","price_per_share":335.24,"price_display":"335.24","price_state":"stated","total_value":531020.16,"total_display":"531,020.16","total_whole":"531,020","shares_owned_after":54303.0,"shares_owned_after_display":"54,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-24","filed_date":"2025-01-27","scope":"insider"},{"id":2515848,"accession":"0000950170-24-105650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-105650","line_url":"/filing/0000950170-24-105650#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001518611","owner_name":"Sibold William John","owner_display_name":"Sibold William John","owner_url":"/insider/0001518611","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6363.0,"shares_display":"6,363","price_per_share":243.83,"price_display":"243.83","price_state":"stated","total_value":1551490.29,"total_display":"1,551,490.29","total_whole":"1,551,490","shares_owned_after":55887.0,"shares_owned_after_display":"55,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001157601","name":"MADRIGAL PHARMACEUTICALS, INC.","url":"/issuer/0001157601","role":"Director, Officer (President and CEO)","n_filings":8,"first_seen":"2024-09-11","last_seen":"2026-07-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001518611","retrieved_at":"2026-08-27T16:01:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}